The IFSO Global Registry Second Report was funded by the International Federation for Surgery for Obesity and Metabolic Disorders.
Conflict of Interests
Dr. Welbourn declares support for attending conferences from Ethicon Endo-Surgery, consultancy fees from Novo Nordisk, funding of a Bariatric Clinical Fellow in Musgrove Park Hospital, Taunton TA1 5DA, UK from Ethicon Endo-Surgery, outside the submitted work. Dr. Dixon declares grants from NHMRC during the conduct of the study; personal fees from Apollo Endo-surgery, Bariatric Advantage, Covidien, iNova Pharmaceuticals, Novartis, Nestle, Novo Nordisk, mdBriefcase outside the submitted work. Dr. Higa declares personal fees from Ethicon, other from Endogastric Solutions outside the submitted work. Dr. Kinsman and Dr. Walton declare grants from IFSO during the conduct of the study, other grant from IFSO outside the submitted work. Dr. Pournaras Dr. Ottosson, Dr. Ramos, Dr. van Wagensveld, Dr. Weiner, and Dr. Zundel declare no conflict of interest.